Castration resistant prostate cancer - Globe Thesis

Keyword [Castration resistant prostate cancer] Result: 101 - 120 \| Page: 6 of 7
101.	Imaging-guided Delivery System Combined With Chemotherapy And Phototherapy For Castration-resistant Prostate Cancer Treatment
102.	PRKAR2B Plays The Oncogenic Roles In The Castration-resistant Prostate Cancer
103.	LncRNA-CYTOR/SRSF4/7 RNA-protein Complex Promotes Crpc Progression Through Regulating Alternative Splicing Of AR-V7
104.	The Role And Mechanism Of LINC00675 In The Development Of Castration Resistant Prostate Cancer
105.	Epithelial-Mesenchymal Transition Biomarkers In Peripheral Blood Predict Docetaxel Efficacy In Patients With Metastatic Castration-Resistant Prostate Cancer
106.	The Potential Value And Mechanism Of Cir-ITCH In The Treatment Of Castration Resistant Prostate Cancer
107.	The Mechanism Research Of PAK2 Phosphorylating TRIM28 In The Progression Of Prostate Cancer
108.	Correlation Between The Expression Of PCAT-1 In Urine And The Clinical Progression Of Castration Resistant Prostate Cancer
109.	FL3 Targeting PHB1 To Inhibit The Malignant Progression Of Castration-resistant Prostate Cancer And Its Molecular Mechanism
110.	Characterization Of LRRN1 In Promoting Enzalutamide Resistance In Castration-resistant Prostate Cancer
111.	Meta-analysis Of The Efficacy And Safety Of Abiraterone Acetate In The Treatment Of Castration-resistant Prostate Cancer
112.	To Explore The Clinical Efficacy Of "Spleen And Dampness And Removing Phlegm Method" Combined With Abiraterone Acetate In The Treatment Of Metastatic Castration-resistant Prostate Cancer Based On The Theory Of "Chuzhuo Peiben"
113.	The Mechanisms Underlying KAT2A-mediated AR Translocation Into Nucleus In Castration-resistant Prostate Cancer Cell With Abiraterone-Resistance
114.	Precise Prognosis Analysis Of Metastatic Castration Resistant Prostate Cancer
115.	Analysis Of Factors Related To MCRPC Progression In Patients With High Tumor Burden MHSPC After Endocrine Therapy
116.	Analysis Of Factors Related To Second Progression Of Castration-resistant Prostate Cancer Treated With Abiraterone Acetate
117.	Correlation Research Between The Early Dynamic Change Of PSA And The Prognosis After Treatment With Abiraterone Acetate For Castration-resistant Prostate Cancer
118.	Study On Cell Model And Mechanism Of Bipolar Androgen Therapy For Castration-resistant Prostate Cancer
119.	Analysis Of Predictors Of Initial Resistance To Abiraterone Acetate In Patients With Metastatic Castration-Resistant Prostate Cancer
120.	Correlation Of Serum Testosterone Concentration Control To Disease Progression In Patients With Advanced Metastatic Prostate Cancer
<<First <Prev Next> Last>> Jump to